JAMES BELL: Open Payments
NPI 1265859508 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 44 payments from 15 companies in 2025. Trend: 2023 $633 · 2024 $1,121 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 8 | $225 |
| E.R. Squibb & Sons, L.L.C. | 7 | $223 |
| Antares Pharma, Inc. | 7 | $189 |
| Lilly USA, LLC | 2 | $153 |
| Novo Nordisk Inc | 4 | $109 |
| PFIZER INC. | 3 | $71 |
| TOLMAR, INC. | 3 | $70 |
| Amgen Inc. | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Inspire Medical Systems, Inc. | 1 | $33 |
Products named: XYOSTED, ELIQUIS, ZEPBOUND, CAMZYOS, AVEED, XIAFLEX, Wegovy, JATENZO.
Industry payments across MA — which companies pay providers there.
